Obesity Drug Race Shifts Focus from Weight Loss to Long-Term Weight Management
Weight Loss Drug Market Could Reach $150 Billion Globally | Morgan Stanley The race to develop obesity drugs is entering a new phase. While the first goal was helping people lose weight, the focus is now shifting toward helping them keep the weight off safely and sustainably. New weight-loss medications known as GLP-1 drugs have … Read more